| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 7.14e-07 | 15 | 98 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB4 SRC PI4K2A ERN2 MST1 CKM NEK2 NUAK1 CSK NRK NIM1K MAST1 PRKD1 PIPSL | 2.12e-05 | 764 | 98 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB4 SRC PI4K2A ERN2 MST1 NEK2 NUAK1 CSK NRK NIM1K MAST1 PRKD1 PIPSL | 4.27e-05 | 709 | 98 | 13 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB4 TENT4A SRC PI4K2A ERN2 MST1 CKM NEK2 NUAK1 CSK NRK NIM1K MAST1 PRKD1 PIPSL | 5.08e-05 | 938 | 98 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.23e-04 | 20 | 98 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.73e-04 | 600 | 98 | 11 | GO:0004672 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 2.28e-04 | 112 | 98 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 3.53e-04 | 6 | 98 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transfer activity | 3.53e-04 | 6 | 98 | 2 | GO:0120019 | |
| GeneOntologyBiologicalProcess | female meiosis II | 7.43e-09 | 6 | 99 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 7.43e-09 | 6 | 99 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 7.43e-09 | 6 | 99 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 3.54e-07 | 31 | 99 | 5 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 6.88e-06 | 26 | 99 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.08e-05 | 29 | 99 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 2.92e-05 | 37 | 99 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 3.46e-05 | 77 | 99 | 5 | GO:0048255 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 6.23e-05 | 87 | 99 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 6.40e-05 | 45 | 99 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 6.58e-05 | 88 | 99 | 5 | GO:0043489 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 7.60e-05 | 47 | 99 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ABCA3 DAZ4 SRC DAZ1 DCC RUVBL2 ARHGEF10L SIRPD FBXO38 NEK2 VPS13D ARRB2 KIDINS220 PRKD1 LIMCH1 DMD DAZ3 DAZ2 | 7.93e-05 | 1366 | 99 | 18 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | DAZ4 SRC DAZ1 RUVBL2 ARHGEF10L NEK2 VPS13D PRKD1 LIMCH1 DAZ3 DAZ2 | 9.70e-05 | 574 | 99 | 11 | GO:0010638 |
| GeneOntologyBiologicalProcess | female gamete generation | 1.01e-04 | 223 | 99 | 7 | GO:0007292 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.07e-04 | 156 | 99 | 6 | GO:0048477 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.13e-04 | 52 | 99 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.27e-04 | 101 | 99 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.33e-04 | 115 | 99 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 2.62e-04 | 118 | 99 | 5 | GO:2000243 | |
| GeneOntologyBiologicalProcess | positive regulation of guanylate cyclase activity | 3.38e-04 | 6 | 99 | 2 | GO:0031284 | |
| GeneOntologyCellularComponent | cell pole | 2.08e-06 | 20 | 98 | 4 | GO:0060187 | |
| GeneOntologyCellularComponent | cell tip | 6.48e-05 | 17 | 98 | 3 | GO:0051286 | |
| GeneOntologyCellularComponent | growing cell tip | 6.51e-05 | 3 | 98 | 2 | GO:0035838 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CASC3 KCNE3 PCLO SRC PI4K2A RGS11 KIRREL3 ARRB2 MAST1 ASTN2 TRPM1 DMD USH2A PREX1 SHISA8 | 5.79e-04 | 1228 | 98 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | glycogen granule | 5.98e-04 | 8 | 98 | 2 | GO:0042587 | |
| GeneOntologyCellularComponent | dendrite | CASC3 KCNE3 PCLO SRC PI4K2A RGS11 KIRREL3 ARRB2 MAST1 TRPM1 PREX1 SHISA8 | 6.72e-04 | 858 | 98 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CASC3 KCNE3 PCLO SRC PI4K2A RGS11 KIRREL3 ARRB2 MAST1 TRPM1 PREX1 SHISA8 | 6.86e-04 | 860 | 98 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | cell projection membrane | 9.55e-04 | 431 | 98 | 8 | GO:0031253 | |
| Domain | Kinase-like_dom | 1.16e-04 | 542 | 97 | 11 | IPR011009 | |
| Domain | PROTEIN_KINASE_ATP | 1.36e-04 | 459 | 97 | 10 | PS00107 | |
| Domain | Prot_kinase_dom | 2.27e-04 | 489 | 97 | 10 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.42e-04 | 493 | 97 | 10 | PS50011 | |
| Domain | WHTH_DNA-bd_dom | 2.68e-04 | 242 | 97 | 7 | IPR011991 | |
| Pathway | WP_OVARIAN_INFERTILITY | 3.60e-05 | 35 | 76 | 4 | MM15948 | |
| Pubmed | 6.43e-11 | 4 | 100 | 4 | 7670487 | ||
| Pubmed | 6.43e-11 | 4 | 100 | 4 | 11694340 | ||
| Pubmed | 6.43e-11 | 4 | 100 | 4 | 9321470 | ||
| Pubmed | 6.43e-11 | 4 | 100 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 6.43e-11 | 4 | 100 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 6.43e-11 | 4 | 100 | 4 | 11688365 | |
| Pubmed | 6.43e-11 | 4 | 100 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 6.43e-11 | 4 | 100 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 6.43e-11 | 4 | 100 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 6.43e-11 | 4 | 100 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 6.43e-11 | 4 | 100 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 6.43e-11 | 4 | 100 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 6.43e-11 | 4 | 100 | 4 | 16963411 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 23579190 | ||
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 3.21e-10 | 5 | 100 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 3.21e-10 | 5 | 100 | 4 | 17416365 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 22293198 | ||
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 3.21e-10 | 5 | 100 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 3.21e-10 | 5 | 100 | 4 | 8968756 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 3.21e-10 | 5 | 100 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 3.21e-10 | 5 | 100 | 4 | 26411291 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 3.21e-10 | 5 | 100 | 4 | 14648873 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 8896558 | ||
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 3.21e-10 | 5 | 100 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 3.21e-10 | 5 | 100 | 4 | 9288969 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 3.21e-10 | 5 | 100 | 4 | 10903443 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 3.21e-10 | 5 | 100 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 3.21e-10 | 5 | 100 | 4 | 8845845 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 3.21e-10 | 5 | 100 | 4 | 19783541 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 17761180 | ||
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 3.21e-10 | 5 | 100 | 4 | 12200456 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 11514340 | ||
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 3.21e-10 | 5 | 100 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 3.21e-10 | 5 | 100 | 4 | 23223451 | |
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 11804965 | ||
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 21270429 | ||
| Pubmed | 3.21e-10 | 5 | 100 | 4 | 8661148 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 9.61e-10 | 6 | 100 | 4 | 18452650 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 9.61e-10 | 6 | 100 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 9.61e-10 | 6 | 100 | 4 | 31355046 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 20157580 | ||
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 9.61e-10 | 6 | 100 | 4 | 26077710 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 17526644 | ||
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 9.61e-10 | 6 | 100 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 9.61e-10 | 6 | 100 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 9.61e-10 | 6 | 100 | 4 | 23417416 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 32170089 | ||
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 16278232 | ||
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 9.61e-10 | 6 | 100 | 4 | 16001084 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 9.61e-10 | 6 | 100 | 4 | 1869307 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 11390979 | ||
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 27632217 | ||
| Pubmed | 2.24e-09 | 7 | 100 | 4 | 15081113 | ||
| Pubmed | 2.24e-09 | 7 | 100 | 4 | 22699423 | ||
| Pubmed | 2.24e-09 | 7 | 100 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 2.24e-09 | 7 | 100 | 4 | 16946704 | |
| Pubmed | 2.24e-09 | 7 | 100 | 4 | 10857750 | ||
| Pubmed | 2.24e-09 | 7 | 100 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 2.24e-09 | 7 | 100 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 2.24e-09 | 7 | 100 | 4 | 26826184 | |
| Pubmed | 2.66e-09 | 20 | 100 | 5 | 22623674 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 4.46e-09 | 8 | 100 | 4 | 23204224 | |
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 29883445 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 10823932 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 11869379 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 4.46e-09 | 8 | 100 | 4 | 32339196 | |
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 33749946 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 22621333 | ||
| Pubmed | 4.46e-09 | 8 | 100 | 4 | 32686646 | ||
| Pubmed | 4.74e-09 | 47 | 100 | 6 | 32892421 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 8.02e-09 | 9 | 100 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 8.02e-09 | 9 | 100 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 8.02e-09 | 9 | 100 | 4 | 19695304 | |
| Pubmed | 8.02e-09 | 9 | 100 | 4 | 28235998 | ||
| Pubmed | 8.02e-09 | 9 | 100 | 4 | 20159962 | ||
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 1.33e-08 | 10 | 100 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 1.33e-08 | 10 | 100 | 4 | 38433229 | |
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 23810942 | ||
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 12837688 | ||
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 10601091 | ||
| Pubmed | 1.33e-08 | 10 | 100 | 4 | 9922113 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 2.09e-08 | 11 | 100 | 4 | 34401671 | |
| Pubmed | High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. | 2.31e-08 | 3 | 100 | 3 | 11870237 | |
| Cytoband | Yq11.223 | 5.33e-05 | 93 | 100 | 4 | Yq11.223 | |
| Cytoband | 2p24 | 3.06e-04 | 12 | 100 | 2 | 2p24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.84e-03 | 797 | 100 | 7 | chr19p13 | |
| Cytoband | 4q24 | 2.52e-03 | 34 | 100 | 2 | 4q24 | |
| Cytoband | 10q24 | 2.67e-03 | 35 | 100 | 2 | 10q24 | |
| GeneFamily | RNA binding motif containing | 1.37e-04 | 213 | 67 | 6 | 725 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 9.64e-08 | 12 | 100 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 9.64e-08 | 12 | 100 | 4 | MM781 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 1.54e-06 | 93 | 100 | 6 | MM1185 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.67e-06 | 23 | 100 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 5.80e-06 | 31 | 100 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 7.50e-06 | 33 | 100 | 4 | MM701 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 184 | 100 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 184 | 100 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 184 | 100 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-06 | 185 | 100 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 190 | 100 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 190 | 100 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 191 | 100 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 100 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.77e-06 | 192 | 100 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-06 | 193 | 100 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 151 | 100 | 5 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.97e-05 | 159 | 100 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 162 | 100 | 5 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 162 | 100 | 5 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.35e-05 | 163 | 100 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.45e-05 | 173 | 100 | 5 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-05 | 174 | 100 | 5 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 5.37e-05 | 180 | 100 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 182 | 100 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.66e-05 | 182 | 100 | 5 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.80e-05 | 183 | 100 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 183 | 100 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-05 | 184 | 100 | 5 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 5.96e-05 | 184 | 100 | 5 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.27e-05 | 186 | 100 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 6.27e-05 | 186 | 100 | 5 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.43e-05 | 187 | 100 | 5 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.43e-05 | 187 | 100 | 5 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 6.59e-05 | 188 | 100 | 5 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-05 | 189 | 100 | 5 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 6.93e-05 | 190 | 100 | 5 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-05 | 191 | 100 | 5 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.11e-05 | 191 | 100 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-05 | 191 | 100 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 7.11e-05 | 191 | 100 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.11e-05 | 191 | 100 | 5 | b680e0c35f1004be36f9f0680ae3c62952e2b607 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.11e-05 | 191 | 100 | 5 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.11e-05 | 191 | 100 | 5 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.11e-05 | 191 | 100 | 5 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.28e-05 | 192 | 100 | 5 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 7.28e-05 | 192 | 100 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 7.46e-05 | 193 | 100 | 5 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.46e-05 | 193 | 100 | 5 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-05 | 195 | 100 | 5 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-05 | 196 | 100 | 5 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.22e-05 | 197 | 100 | 5 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-05 | 197 | 100 | 5 | e14a0e8a893c72356afc5508e3531ae0b23bfe16 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.22e-05 | 197 | 100 | 5 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-05 | 197 | 100 | 5 | 19cf283537c853fa902852e7b8ac1139729a931a | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 8.42e-05 | 198 | 100 | 5 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.42e-05 | 198 | 100 | 5 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.42e-05 | 198 | 100 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.42e-05 | 198 | 100 | 5 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.42e-05 | 198 | 100 | 5 | 9c0535099750698daac5d6b4d39fb19fecf4ffde | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 200 | 100 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 200 | 100 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 1.76e-04 | 124 | 100 | 4 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 125 | 100 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 49 | 100 | 3 | 1695b90c48e65d90f4e6a2a88d8593d502266b46 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 49 | 100 | 3 | 90c5c9d6ce009db7fbc26f410b4f27ca74f738a3 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 49 | 100 | 3 | 79fc6b69cd2cb891f0e0106c2ad0e2b8e3e13071 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 129 | 100 | 4 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.36e-04 | 134 | 100 | 4 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.50e-04 | 136 | 100 | 4 | 5e209185b5f6e9347829fc9066f0b2c3711df057 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.72e-04 | 139 | 100 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.28e-04 | 146 | 100 | 4 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma-2|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.28e-04 | 146 | 100 | 4 | bc2adef529d0bbfcccef7435401a47a6ffcc1832 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.28e-04 | 146 | 100 | 4 | 72c1e7e0c2b6ff6c4084af61fa19c2b8eab16eda | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-04 | 149 | 100 | 4 | c773c2b9685ec44a35246180a93456c8765353f5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 150 | 100 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.91e-04 | 153 | 100 | 4 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 4.21e-04 | 156 | 100 | 4 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 156 | 100 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.31e-04 | 157 | 100 | 4 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK_CD56bright|ICU-SEP / Disease, Lineage and Cell Type | 4.42e-04 | 158 | 100 | 4 | 53a942cdab4a3c6813dbe11368135a24b8de1880 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 160 | 100 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-04 | 160 | 100 | 4 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 160 | 100 | 4 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 160 | 100 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 4.63e-04 | 160 | 100 | 4 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.74e-04 | 161 | 100 | 4 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 162 | 100 | 4 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-04 | 163 | 100 | 4 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 164 | 100 | 4 | fe11fcce4ba7f44ba2989ea3705916b67e75f8e7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 164 | 100 | 4 | f4de9f18134a06f3d7fcf5b50b8e21c1506e2083 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 164 | 100 | 4 | dc22b1fef49c1557a0b63c536eaba574dfcab715 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 164 | 100 | 4 | b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-04 | 165 | 100 | 4 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-04 | 165 | 100 | 4 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.20e-04 | 165 | 100 | 4 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-04 | 165 | 100 | 4 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| Drug | boron trichloride | 5.01e-09 | 6 | 99 | 4 | CID000025135 | |
| Drug | 3-bromo-7-nitroindazole | 1.02e-08 | 36 | 99 | 6 | CID000001649 | |
| Drug | Trichlormethiazide [133-67-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | RNF19B PI4K2A RAD54L2 ERN2 VPS13D KIDINS220 MIA2 ASTN2 ARHGAP45 | 2.28e-07 | 200 | 99 | 9 | 4783_DN |
| Drug | NSC56408 | 2.93e-07 | 62 | 99 | 6 | CID000005604 | |
| Drug | desmethylazelastine | 5.88e-07 | 16 | 99 | 4 | CID000162558 | |
| Drug | dazmegrel | 1.24e-06 | 19 | 99 | 4 | CID000053555 | |
| Drug | YM 026 | 1.24e-06 | 19 | 99 | 4 | CID000004443 | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.57e-06 | 199 | 99 | 8 | 4119_DN | |
| Drug | AZFd | 2.79e-06 | 23 | 99 | 4 | CID000196489 | |
| Drug | dansylaziridine | 2.79e-06 | 23 | 99 | 4 | CID000104008 | |
| Drug | d-gluconhydroximo-1,5-lactam | 9.67e-06 | 31 | 99 | 4 | CID000003479 | |
| Drug | BWA1433 | 1.71e-05 | 12 | 99 | 3 | CID006439089 | |
| Drug | Vistar | 1.78e-05 | 36 | 99 | 4 | CID000040896 | |
| Drug | p11-13 | 1.90e-05 | 75 | 99 | 5 | CID000015759 | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 7268_UP | |
| Drug | BW A1433U | 3.49e-05 | 15 | 99 | 3 | CID000122071 | |
| Drug | molybdenum disulfide | 3.64e-05 | 43 | 99 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 3.64e-05 | 43 | 99 | 4 | CID000072194 | |
| Drug | EKB-569 | 3.91e-05 | 87 | 99 | 5 | CID006445562 | |
| Drug | propham | 3.99e-05 | 44 | 99 | 4 | CID000024685 | |
| Drug | gemfibrozil | 5.31e-05 | 222 | 99 | 7 | CID000003463 | |
| Drug | Zm 241385 | 6.13e-05 | 49 | 99 | 4 | CID000176407 | |
| Drug | bipy | 6.59e-05 | 97 | 99 | 5 | CID000001474 | |
| Drug | ridogrel | 7.76e-05 | 52 | 99 | 4 | CID005362391 | |
| Disease | Male sterility due to Y-chromosome deletions | 8.26e-09 | 8 | 99 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 8.26e-09 | 8 | 99 | 4 | C1507149 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.97e-06 | 27 | 99 | 4 | DOID:10584 (implicated_via_orthology) | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.99e-05 | 16 | 99 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.99e-05 | 16 | 99 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.99e-05 | 16 | 99 | 3 | 415000 | |
| Disease | platelet component distribution width | EPHB4 TENT4A MYO9B ZZEF1 JMY SIRPD MIA2 PREX1 NOS3 BRWD1 SPIC | 4.67e-05 | 755 | 99 | 11 | EFO_0007984 |
| Disease | Benign Neoplasm | 8.23e-05 | 68 | 99 | 4 | C0086692 | |
| Disease | Neoplasms | 8.23e-05 | 68 | 99 | 4 | C0027651 | |
| Disease | Colorectal Carcinoma | TET2 ABCA3 SRC DCC ARHGEF10L ABCD3 PRKD1 DMD SNRNP200 AGTPBP1 | 1.27e-04 | 702 | 99 | 10 | C0009402 |
| Disease | major depressive disorder | 1.80e-04 | 155 | 99 | 5 | MONDO_0002009 | |
| Disease | unipolar depression, bipolar disorder | 1.86e-04 | 156 | 99 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Malignant neoplasm of breast | EPHB4 ABCA3 SRC TRMT11 ATP8B1 ADAR MST1 FASN MIA2 ASTN2 DMD NOS3 | 2.55e-04 | 1074 | 99 | 12 | C0006142 |
| Disease | Colorectal Neoplasms | 3.50e-04 | 277 | 99 | 6 | C0009404 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 3.56e-04 | 41 | 99 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | neurotic disorder | 3.79e-04 | 101 | 99 | 4 | EFO_0004257 | |
| Disease | birth weight | 4.02e-04 | 399 | 99 | 7 | EFO_0004344 | |
| Disease | Retinitis Pigmentosa | 4.24e-04 | 104 | 99 | 4 | C0035334 | |
| Disease | birth weight, parental genotype effect measurement | 4.83e-04 | 192 | 99 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 4.89e-04 | 108 | 99 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 4.93e-04 | 10 | 99 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | wellbeing measurement | 5.40e-04 | 692 | 99 | 9 | EFO_0007869 | |
| Disease | Oligospermia | 7.20e-04 | 12 | 99 | 2 | C0028960 | |
| Disease | Disorder of eye | 7.56e-04 | 212 | 99 | 5 | C0015397 | |
| Disease | Metastatic melanoma | 8.03e-04 | 54 | 99 | 3 | C0278883 | |
| Disease | waist-hip ratio | TET2 MYO9B TRMT11 ZZEF1 ANGPTL8 RSRC1 ADORA2B KIDINS220 CSK ASTN2 PIPSL ELL | 8.28e-04 | 1226 | 99 | 12 | EFO_0004343 |
| Disease | Malignant Neoplasms | 9.25e-04 | 128 | 99 | 4 | C0006826 | |
| Disease | neuroticism measurement | KCNE3 PPP1R3B PCLO DCC RSRC1 ARHGEF10L KIRREL3 PLCL2 ASTN2 PRKD1 | 9.63e-04 | 909 | 99 | 10 | EFO_0007660 |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 9.88e-04 | 14 | 99 | 2 | EFO_0006830, EFO_0006896 | |
| Disease | body weight | TET2 TENT4A DCC ZZEF1 LRP1B GPR139 FASN FEZ2 ASTN2 PRKD1 DMD NOS3 | 1.06e-03 | 1261 | 99 | 12 | EFO_0004338 |
| Disease | Pre-Eclampsia | 1.30e-03 | 16 | 99 | 2 | C0032914 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.50e-03 | 801 | 99 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | executive function measurement | 1.70e-03 | 376 | 99 | 6 | EFO_0009332 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 1.84e-03 | 19 | 99 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder | 1.92e-03 | 156 | 99 | 4 | EFO_0003756 | |
| Disease | Mammary Carcinoma, Human | 1.97e-03 | 525 | 99 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.97e-03 | 525 | 99 | 7 | C1257931 | |
| Disease | Retinitis pigmentosa | 2.00e-03 | 74 | 99 | 3 | cv:C0035334 | |
| Disease | Mammary Neoplasms | 2.02e-03 | 527 | 99 | 7 | C1458155 | |
| Disease | smoking status measurement, diastolic blood pressure | 2.05e-03 | 159 | 99 | 4 | EFO_0006336, EFO_0006527 | |
| Disease | breast carcinoma | 2.24e-03 | 1019 | 99 | 10 | EFO_0000305 | |
| Disease | gastric ulcer | 2.24e-03 | 21 | 99 | 2 | EFO_0009454 | |
| Disease | Breast Carcinoma | 2.26e-03 | 538 | 99 | 7 | C0678222 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 2.27e-03 | 398 | 99 | 6 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Esophageal Neoplasms | 2.32e-03 | 78 | 99 | 3 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 2.32e-03 | 78 | 99 | 3 | C0546837 | |
| Disease | portal hypertension (biomarker_via_orthology) | 2.46e-03 | 22 | 99 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | Cardiomegaly | 2.68e-03 | 82 | 99 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.68e-03 | 82 | 99 | 3 | C1383860 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.87e-03 | 84 | 99 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Septicemia | 2.93e-03 | 24 | 99 | 2 | C0036690 | |
| Disease | Sepsis | 2.93e-03 | 24 | 99 | 2 | C0243026 | |
| Disease | Severe Sepsis | 2.93e-03 | 24 | 99 | 2 | C1719672 | |
| Disease | Pyemia | 2.93e-03 | 24 | 99 | 2 | C0034189 | |
| Disease | initial pursuit acceleration | 3.17e-03 | 87 | 99 | 3 | EFO_0008434 | |
| Disease | depressive symptom measurement | 3.17e-03 | 426 | 99 | 6 | EFO_0007006 | |
| Disease | colon adenocarcinoma (is_marker_for) | 3.18e-03 | 25 | 99 | 2 | DOID:234 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLEEKRKSLRTTGFY | 881 | Q4LE39 | |
| TVYGDRGQLIKSKER | 546 | Q9HCE6 | |
| TRSRSAIVIKAGGRY | 141 | P55199 | |
| LRYKSLVTGTRARGV | 111 | P29275 | |
| TTGIIYAQRRLKKRG | 451 | Q4VNC1 | |
| LVRTYSGGNKRKLST | 1511 | Q99758 | |
| KGSLVDYLRSRGRSV | 271 | P41240 | |
| GVYRTTEGRLTKARN | 51 | Q6UXH0 | |
| YDTGRTGRIRVLSFK | 3186 | P11532 | |
| IRGTKGTYIRTSDGR | 1101 | Q9Y4B4 | |
| LKSKTNARRAVDRGY | 231 | Q9UPW5 | |
| GRYGSVKEVKIITNR | 61 | Q13117 | |
| GRYGSVKEVKIITNR | 61 | Q9NR90 | |
| SYRVKVKLVVSRGGD | 321 | P32121 | |
| EQYRSRRRSKGLLKS | 416 | O75129 | |
| GYADLISSGRSIRKK | 1216 | O43520 | |
| KKKRGSYRGGSISVQ | 676 | Q14978 | |
| EYFRKALGRTRVKSS | 231 | O94810 | |
| TGYKIRHRKTTRRGE | 656 | P43146 | |
| KLGSKTALNRRDTYR | 891 | Q9ULH0 | |
| IGREKRSNSQSYIGR | 241 | Q15139 | |
| RTKGIYRVNGVKTRV | 791 | Q92619 | |
| RAILRSNKYTGGDTK | 2426 | Q9NZR2 | |
| ARRGRVSAKKSYLRN | 611 | Q8N9B5 | |
| TGSYGRCQKIRRKSD | 16 | P51955 | |
| IKTLKGGYTERQRRE | 646 | P54760 | |
| TERNGSLYKKSDGIR | 306 | O43150 | |
| RKFRSYKGTSVRDLL | 836 | Q76MJ5 | |
| ILGYTRSRKVDKRSD | 76 | Q9Y6H6 | |
| LSGYRIRLGSSTDKK | 181 | Q16206 | |
| RVRTVKGQDYLSKTG | 206 | Q5T0W9 | |
| TRSRRKARVGKYGDS | 3486 | Q9Y6V0 | |
| RGKGKLQDSVGYRIS | 46 | P55157 | |
| RLSTGRGYVSQKRKE | 846 | P55157 | |
| RGYVSQKRKESVLAG | 851 | P55157 | |
| IEFRKRYSTKGGEVR | 351 | Q86W56 | |
| LKKGSRVYRGIRHTS | 416 | Q8IY84 | |
| QRSGKKYGFTLRAIR | 971 | Q9Y2H9 | |
| GRRKRENKASTYGLN | 166 | Q5XG87 | |
| DLKGSTYRRRASQKE | 206 | A2A3N6 | |
| KRVKATILYGSETGR | 516 | P29474 | |
| FNYSAIDRVKSRGKR | 221 | Q9BTU6 | |
| KNGTRRYSEREEKTG | 616 | Q6PIJ6 | |
| QYRIRKRGNRKSSTS | 436 | Q92794 | |
| SEEKTGKRRSAAYVR | 556 | A4D1B5 | |
| ARRTVRVYKGNKSFG | 276 | A4D2P6 | |
| KKSYSRARRTRTKVG | 401 | O15234 | |
| GRYGSVKEVKIITNR | 61 | Q9NQZ3 | |
| GRYGSVKEVKIITNR | 226 | Q9NQZ3 | |
| GRYGSVKEVKIITNR | 391 | Q9NQZ3 | |
| VGRVSIYDSKRQSGK | 1106 | P55265 | |
| LRKRRDTGGNTYTAK | 881 | A8TX70 | |
| GATTVRYKGRNLRIK | 276 | Q96RY5 | |
| TDVLRSAAKFYRRKG | 241 | O14879 | |
| NGCGRKATRKRVYLS | 1591 | Q9NSI6 | |
| NGATYSKTLLRDGKR | 191 | Q8IZU9 | |
| GRYGSVKEVKIITNR | 61 | Q86SG3 | |
| GRYGSVKEVKIITNR | 226 | Q86SG3 | |
| SRDKYGLDRTGLSKV | 581 | Q49AJ0 | |
| RRKSNFRLRGYSTGK | 211 | Q6DWJ6 | |
| EQYRGTVSKTRKGVQ | 376 | P26927 | |
| SRSGIRTGYQAKQVR | 1916 | P49327 | |
| GELKKGDTIYNTRTR | 376 | Q96RP9 | |
| KKRRGDRYSVQTSLI | 3496 | P21817 | |
| KGIVRAKRRGTSYLT | 51 | Q7RTP0 | |
| LKRSSTGSYEERVKR | 201 | Q9UHY8 | |
| GTSERRKSIKTYREI | 401 | Q9UPQ0 | |
| RGKNYRIIRAELKST | 226 | Q86XI6 | |
| FRSVRSRLYVGREKK | 671 | Q96PC5 | |
| IGRRVRVNKYQKSVG | 66 | Q7Z2Y5 | |
| KISKLGRSFTRARDY | 201 | Q9Y230 | |
| SYGRGLSKAVRARTK | 3481 | O75445 | |
| CGKKRRYVRLGLSSS | 231 | Q5MJ70 | |
| KIRKLDSGGFYITSR | 206 | P12931 | |
| YGIRESTRRTGSQKE | 311 | Q7Z4G4 | |
| GRKIHSRYEGRKTSK | 381 | Q6ZMZ0 | |
| SYSRRKHGKRIGVQG | 1001 | Q96KN7 | |
| YAKTKTRAEVRGGGR | 111 | Q9BYD3 | |
| VLSSRVRTGRSIKGY | 126 | P06732 | |
| VRKGKKSREYASLRT | 896 | Q9UPR0 | |
| TDTATRRNVRKGYKP | 151 | Q9Y448 | |
| RTKSINGSLYIFRGR | 316 | Q8TCU6 | |
| SRRGRYEKIHGRSKE | 571 | Q9NWH9 | |
| GRGSRYLRTNSKTEV | 381 | B8ZZ34 | |
| KTRLTLRRTGQYKGL | 211 | Q8N5S1 | |
| YGKVKRATERFSGRV | 66 | O60285 | |
| GSTSSRSRLYRKKRV | 66 | Q99457 | |
| KKGVRATGTIRENRT | 641 | Q96JS3 | |
| YGRSGEITKIRRKLT | 176 | Q8N5J4 | |
| ESGIIGRSRKDFKRY | 111 | P28288 | |
| YVRAGKGNVTRRRKK | 71 | Q5K130 | |
| SGRRYNLKVKRGRVV | 251 | Q8NEY3 | |
| AGRKRRRSKTSNYLI | 321 | O00295 | |
| SKRYLTNKVDRSVGG | 676 | O15067 | |
| VRSFLKRSKLGRYNE | 121 | Q99426 | |
| IKGRAIKEYQSGRGT | 121 | Q9H106 | |
| DSRTYSRKKGGRKSR | 31 | Q96IZ7 | |
| GKSYRVQRSRSKSRT | 91 | Q96IZ7 | |
| KSRSFVYSRGRKLVG | 1436 | Q7Z4N2 | |
| ITRKGGERTYTQLVR | 596 | O75643 | |
| GARAKTVEVGRYKGR | 1206 | A7E2V4 | |
| TDARGRKTRYDTKVG | 1141 | O43149 | |
| RIERVIYTGKEGKSS | 1176 | Q6N021 | |
| RARAKYVRGNLSSKE | 26 | Q8NBT3 | |
| REKYGRKIATASIGG | 1186 | Q5THJ4 | |
| LGNVTYKKRATGREE | 411 | Q13459 |